수의학 CT 영상 시장 규모, 점유율 및 동향 분석 보고서 : 솔루션별, 동물별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Veterinary CT Imaging Market Summary

The global veterinary CT imaging market size was estimated at USD 421.4 million in 2024 and is projected to reach USD 784.0 million by 2033, growing at a CAGR of 7.17% from 2025 to 2033. Some of the key factors driving market growth are rising demand for advanced diagnostic accuracy, technological advancements in veterinary CT systems, and expansion of veterinary specialty clinics and hospitals.

As veterinary cases become more complex and pet owners increasingly expect human-grade care, the demand for precise diagnostic imaging has risen distinctly, leading to greater adoption of CT technology across clinics and hospitals. This increased expectation for accuracy leads veterinarians to rely on CT imaging to detect subtle fractures, soft-tissue lesions, neurological disorders, and internal abnormalities that conventional X-ray cannot capture. As a result, clinics invest in modern CT scanners to improve case outcomes, reduce diagnostic uncertainty, and enhance surgical planning.

For instance, in September 2025, Modern Animal's rapid growth and new funding strengthened its tech-enabled care model, enhancing imaging workflows, improved diagnostic precision, and supported veterinarians with AI-driven tools that accelerated accurate clinical decision-making.

In addition, rapid innovation such as reduced scan times, enhanced image resolution, and lower radiation exposure has transformed veterinary CT systems, causing broader acceptance across diverse practice settings. Newer scanners accommodate animals of varying sizes, minimize anesthesia requirements, and deliver faster results, making CT imaging more efficient and pet-friendly. These improvements encourage veterinarians to replace older systems with modern models to improve patient throughput and clinical confidence. As equipment becomes more compact, affordable, and digitally integrated, even mid-size clinics adopt CT technology, increasing overall market penetration.

Moreover, increasing cases of trauma, orthopedic injuries, cancer, respiratory diseases, and age-related chronic conditions in pets. According to a report, as of March 2024, 407 dogs in the study had been diagnosed with hemangiosarcoma, and despite treatment, approximately 90% succumb within a year of diagnosis. Such rising number of disease overload creates a strong clinical need for advanced imaging, causing veterinarians to rely more heavily on CT diagnostics. Besides this, as companion animals live longer and lifestyle-related disorders become more common, CT imaging becomes essential for timely detection and treatment planning. This clinical complexity pushes veterinarians to adopt systems capable of detailed 3D visualization and rapid assessment. The rising caseload also drives clinics to improve diagnostic efficiency, prompting investment in in-house CT capabilities to reduce external referrals.

Furthermore, rapid growth of veterinary specialty centers, emergency hospitals, and referral practices has increased the demand for sophisticated diagnostic tools, causing expanded adoption of CT imaging systems. For instance, in October 2025, government approved a project to rebuild a modern multi-specialty veterinary hospital in Mumbai, India, offering advanced care for pets and stray animals. Besides this, as more clinics offer advanced services in neurology, oncology, orthopedics, and internal medicine, they require high-resolution imaging to support accurate case evaluations and specialized treatments. This expansion leads hospitals to integrate CT scanners to enhance diagnostic capabilities, reduce referral delays, and remain competitive within regional networks. In addition, professionalization of veterinary care encourages continuous infrastructure upgrades, resulting in greater market penetration of advanced CT systems. Thus, this institutional growth drives consistent demand for high-performance imaging technologies.

Global Veterinary CT Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary CT imaging market report based on animal, solutions, application, end use, and region.

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Small Animals
  • Dogs
  • Cats
  • Others
• Large Animals
• Solutions Outlook (Revenue, USD Million, 2021 - 2033)
• Equipment
  • Slice CT
  • Cone Beam
• Consumables
• CT Imaging Software & Services
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Neurology
• Orthopedic & Traumatology
• Oncology
• Dental
• Other Applications
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal
  • 1.2.2. Solutions
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom-Up Analysis
  • 1.7.3. Model 3 Volume-Pricing Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising of Veterinary Specialty Clinics and Hospitals
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Equipment Costs and Maintenance Expenses
    • 3.2.2.2. Limited Awareness and Adoption in Emerging Veterinary Practices
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Technology Landscape
• 3.4. Product Pricing Analysis
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary CT Imaging Market: By Solutions Estimates & Trend Analysis

• 4.1. Veterinary CT Imaging Market, By Solutions: Segment Dashboard
• 4.2. Veterinary CT Imaging Market, By Solutions Movement Analysis
• 4.3. Veterinary CT Imaging Market Estimates & Forecasts, by Solutions, 2021 to 2033 (USD Million)
• 4.4. Equipment
  • 4.4.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Slice CT
    • 4.4.2.1. Slice CT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Cone Beam
    • 4.4.3.1. Cone Beam Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. CT Imaging Software & Services
  • 4.6.1. CT Imaging Software & Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary CT Imaging Market: By Animal Estimates & Trend Analysis

• 5.1. Veterinary CT Imaging Market, By Animal: Segment Dashboard
• 5.2. Veterinary CT Imaging Market, By Animal Movement Analysis
• 5.3. Veterinary CT Imaging Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 5.4. Small Animals
  • 5.4.1. Small Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Dogs
    • 5.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Cats
    • 5.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Large Animals
  • 5.5.1.1. Large Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. Veterinary CT Imaging Market: By Application Estimates & Trend Analysis

• 6.1. Veterinary CT Imaging Market, By Application: Segment Dashboard
• 6.2. Veterinary CT Imaging Market, By Application Movement Analysis
• 6.3. Veterinary CT Imaging Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
• 6.4. Neurology
  • 6.4.1. Neurology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.5. Orthopedic & Traumatology
  • 6.5.1. Orthopedic & Traumatology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.6. Oncology
  • 6.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.7. Dental
  • 6.7.1. Dental Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.8. Other Applications
  • 6.8.1. Other Applications Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. Veterinary CT Imaging Market: By End Use Estimates & Trend Analysis

• 7.1. Veterinary CT Imaging Market, By End Use: Segment Dashboard
• 7.2. Veterinary CT Imaging Market, By End Use Movement Analysis
• 7.3. Veterinary CT Imaging Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 7.4. Veterinary Hospitals & Clinics
  • 7.4.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.5. Diagnostic Laboratories
  • 7.5.1. Diagnostic Laboratories Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Veterinary CT Imaging Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2024 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario

. Regulatory Framework

• 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.3.3. Canada
  • 8.3.3.1. Key Country Dynamics
  • 8.3.3.2. Competitive Scenario
  • 8.3.3.3. Regulatory Framework
  • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.3.4. Mexico
  • 8.3.4.1. Key Country Dynamics
  • 8.3.4.2. Competitive Scenario
  • 8.3.4.3. Regulatory Framework
  • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. GE Healthcare
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product/Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Canon Medical Systems Corporation
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product/Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Epica International (Epica Animal Health)
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product/Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Neurologica Corporation
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product/Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Siemens Healthcare Limited
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product/Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Sound
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product/Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Hallmarq Veterinary Imaging
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product/Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Shenzhen Anke High-Tech Co. Ltd
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product/Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Xoran Technologies, LLC.
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product/Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. PLANMED OY
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product/Service Benchmarking
    • 9.3.10.4. Strategic Initiatives